# Xerox Holdings Corp: financial statements, quarterly

XRX · Nasdaq · CIK 1770450 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xrx.md) · [Financials](/companies/xrx/financials.md) · [Filings](/companies/xrx/filings.md) · [Insiders](/companies/xrx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xrx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,652](/filings/0001770450-24-000050.md) | [1,765 d](/filings/0001770450-26-000009.md) | [1,502](/filings/0001770450-25-000026.md) | [1,578](/filings/0001628280-25-038980.md) | [1,528](/filings/0001770450-25-000037.md) | [1,613 d](/filings/0001770450-26-000009.md) | [1,457](/filings/0001770450-26-000030.md) | [1,576](/filings/0001770450-26-000040.md) | [1,961](/filings/0001770450-25-000037.md) | [2,028 d](/filings/0001770450-26-000009.md) | [1,846](/filings/0001770450-26-000030.md) | [1,922](/filings/0001770450-26-000040.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | [22.0](/filings/0001770450-26-000030.md) | [59.0](/filings/0001770450-26-000040.md) | not reported | not reported | [72.0](/filings/0001770450-26-000030.md) | [203](/filings/0001770450-26-000040.md) |
| Selling, general and administrative | $m | [416](/filings/0001770450-24-000050.md) | [440 d](/filings/0001770450-26-000009.md) | [397](/filings/0001770450-25-000026.md) | [393](/filings/0001628280-25-038980.md) | [370](/filings/0001770450-25-000037.md) | [377 d](/filings/0001770450-26-000009.md) | [378](/filings/0001770450-26-000030.md) | [368](/filings/0001770450-26-000040.md) | [477](/filings/0001770450-25-000037.md) | [431 d](/filings/0001770450-26-000009.md) | [430](/filings/0001770450-26-000030.md) | [432](/filings/0001770450-26-000040.md) |
| Interest expense | $m | [44.0](/filings/0001770450-24-000050.md) | [58.0 d](/filings/0001770450-26-000009.md) | [53.0](/filings/0001770450-25-000026.md) | [60.0](/filings/0001628280-25-038980.md) | [57.0](/filings/0001770450-25-000037.md) | [55.0 d](/filings/0001770450-26-000009.md) | [55.0](/filings/0001770450-26-000030.md) | [78.0](/filings/0001770450-26-000040.md) | [101](/filings/0001770450-25-000037.md) | [100 d](/filings/0001770450-26-000009.md) | [103](/filings/0001770450-26-000030.md) | [118](/filings/0001770450-26-000040.md) |
| Income tax | $m | [15.0](/filings/0001770450-24-000050.md) | [(30.0) d](/filings/0001770450-26-000009.md) | [(37.0)](/filings/0001770450-25-000026.md) | [7.0](/filings/0001628280-25-038980.md) | [118](/filings/0001770450-25-000037.md) | [17.0 d](/filings/0001770450-26-000009.md) | [23.0](/filings/0001770450-26-000030.md) | [46.0](/filings/0001770450-26-000040.md) | [460](/filings/0001770450-25-000037.md) | [12.0 d](/filings/0001770450-26-000009.md) | [32.0](/filings/0001770450-26-000030.md) | [18.0](/filings/0001770450-26-000040.md) |
| Net income | $m | [49.0](/filings/0001770450-24-000050.md) | [(58.0) d](/filings/0001770450-26-000009.md) | [(113)](/filings/0001770450-25-000026.md) | [18.0](/filings/0001628280-25-038980.md) | [(1,205)](/filings/0001770450-25-000037.md) | [(21.0) d](/filings/0001770450-26-000009.md) | [(90.0)](/filings/0001770450-26-000030.md) | [(106)](/filings/0001770450-26-000040.md) | [(760)](/filings/0001770450-25-000037.md) | [(73.0) d](/filings/0001770450-26-000009.md) | [(105)](/filings/0001770450-26-000030.md) | [13.0](/filings/0001770450-26-000040.md) |
| Diluted EPS | $ per share | [0.28](/filings/0001770450-24-000050.md) | not reported | [(0.94)](/filings/0001770450-25-000026.md) | [0.11](/filings/0001628280-25-038980.md) | [(9.71)](/filings/0001770450-25-000037.md) | not reported | [(0.75)](/filings/0001770450-26-000030.md) | [(0.87)](/filings/0001770450-26-000040.md) | [(6.01)](/filings/0001770450-25-000037.md) | not reported | [(0.84)](/filings/0001770450-26-000030.md) | [0.07](/filings/0001770450-26-000040.md) |
| Basic EPS | $ per share | [0.29](/filings/0001770450-24-000050.md) | not reported | [(0.94)](/filings/0001770450-25-000026.md) | [0.12](/filings/0001628280-25-038980.md) | [(9.71)](/filings/0001770450-25-000037.md) | not reported | [(0.75)](/filings/0001770450-26-000030.md) | [(0.87)](/filings/0001770450-26-000040.md) | [(6.01)](/filings/0001770450-25-000037.md) | not reported | [(0.84)](/filings/0001770450-26-000030.md) | [0.07](/filings/0001770450-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001770450-23-000050.md) | [0.5](/filings/0001770450-25-000010.md) | [0.7](/filings/0001770450-24-000031.md) | [0.5](/filings/0001770450-24-000042.md) | [0.5](/filings/0001770450-24-000050.md) | [0.6](/filings/0001770450-26-000009.md) | [0.3](/filings/0001770450-25-000026.md) | [0.4](/filings/0001628280-25-038980.md) | [0.5](/filings/0001770450-25-000037.md) | [0.5](/filings/0001770450-26-000040.md) | [0.6](/filings/0001770450-26-000030.md) | [0.5](/filings/0001770450-26-000040.md) |
| Current assets | $bn | [3.4](/filings/0001770450-23-000050.md) | [3.2](/filings/0001770450-25-000010.md) | [3.3](/filings/0001770450-24-000031.md) | [3.1](/filings/0001770450-24-000042.md) | [3.0](/filings/0001770450-24-000050.md) | [2.9](/filings/0001770450-26-000009.md) | [2.9](/filings/0001770450-25-000026.md) | [3.5](/filings/0001628280-25-038980.md) | [3.8](/filings/0001770450-25-000037.md) | [3.6](/filings/0001770450-26-000040.md) | [3.8](/filings/0001770450-26-000030.md) | [3.7](/filings/0001770450-26-000040.md) |
| Total assets | $bn | [10.4](/filings/0001770450-23-000050.md) | [10.0](/filings/0001770450-25-000010.md) | [9.9](/filings/0001770450-24-000031.md) | [9.5](/filings/0001770450-24-000042.md) | [8.3](/filings/0001770450-24-000050.md) | [8.4](/filings/0001770450-26-000009.md) | [8.2](/filings/0001770450-25-000026.md) | [8.9](/filings/0001628280-25-038980.md) | [10.1](/filings/0001770450-25-000037.md) | [9.8](/filings/0001770450-26-000040.md) | [9.9](/filings/0001770450-26-000030.md) | [9.7](/filings/0001770450-26-000040.md) |
| Current liabilities | $bn | [3.0](/filings/0001770450-23-000050.md) | [2.8](/filings/0001770450-25-000010.md) | [2.4](/filings/0001770450-24-000031.md) | [2.0](/filings/0001770450-24-000042.md) | [2.4](/filings/0001770450-24-000050.md) | [2.6](/filings/0001770450-26-000009.md) | [2.6](/filings/0001770450-25-000026.md) | [2.4](/filings/0001628280-25-038980.md) | [3.4](/filings/0001770450-25-000037.md) | [3.2](/filings/0001770450-26-000040.md) | [3.2](/filings/0001770450-26-000030.md) | [3.1](/filings/0001770450-26-000040.md) |
| Total liabilities | $bn | [7.4](/filings/0001770450-23-000050.md) | [7.2](/filings/0001770450-25-000010.md) | [7.3](/filings/0001770450-24-000031.md) | [6.9](/filings/0001770450-24-000042.md) | [6.8](/filings/0001770450-24-000050.md) | [7.1](/filings/0001770450-26-000009.md) | [6.9](/filings/0001770450-25-000026.md) | [7.5](/filings/0001628280-25-038980.md) | [9.5](/filings/0001770450-25-000037.md) | [9.2](/filings/0001770450-26-000040.md) | [9.4](/filings/0001770450-26-000030.md) | [9.2](/filings/0001770450-26-000040.md) |
| Long-term debt | $bn | [2.7](/filings/0001770450-23-000050.md) | [2.7](/filings/0001770450-25-000010.md) | [3.2](/filings/0001770450-24-000031.md) | [3.2](/filings/0001770450-24-000042.md) | [2.8](/filings/0001770450-24-000050.md) | [2.8](/filings/0001770450-26-000009.md) | [2.7](/filings/0001770450-25-000026.md) | [3.5](/filings/0001628280-25-038980.md) | [4.1](/filings/0001770450-25-000037.md) | [4.0](/filings/0001770450-26-000040.md) | [4.3](/filings/0001770450-26-000030.md) | [4.2](/filings/0001770450-26-000040.md) |
| Current portion of debt | $bn | [0.9](/filings/0001770450-23-000050.md) | [0.6](/filings/0001770450-25-000010.md) | [0.4](/filings/0001770450-24-000031.md) | [0.1](/filings/0001770450-24-000042.md) | [0.5](/filings/0001770450-24-000050.md) | [0.6](/filings/0001770450-26-000009.md) | [0.6](/filings/0001770450-25-000026.md) | [0.5](/filings/0001628280-25-038980.md) | [0.4](/filings/0001770450-25-000037.md) | [0.2](/filings/0001770450-26-000009.md) | [0.2](/filings/0001770450-26-000030.md) | [0.1](/filings/0001770450-26-000040.md) |
| Shareholders' equity | $bn | [2.8](/filings/0001770450-23-000050.md) | [2.5](/filings/0001770450-25-000010.md) | [2.4](/filings/0001770450-24-000031.md) | [2.4](/filings/0001770450-24-000042.md) | [1.3](/filings/0001770450-24-000050.md) | [1.1](/filings/0001770450-26-000009.md) | [1.1](/filings/0001770450-25-000026.md) | [1.1](/filings/0001628280-25-038980.md) | [0.4](/filings/0001770450-25-000037.md) | [0.4](/filings/0001770450-26-000040.md) | [0.3](/filings/0001770450-26-000030.md) | [0.3](/filings/0001770450-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [124 d](/filings/0001770450-24-000050.md) | [389 d](/filings/0001770450-26-000009.md) | [(79.0)](/filings/0001770450-25-000026.md) | [123 d](/filings/0001628280-25-038980.md) | [116 d](/filings/0001770450-25-000037.md) | [351 d](/filings/0001770450-26-000009.md) | [(89.0)](/filings/0001770450-26-000030.md) | [(11.0) d](/filings/0001770450-26-000040.md) | [116 d](/filings/0001770450-25-000037.md) | [208 d](/filings/0001770450-26-000009.md) | [(144)](/filings/0001770450-26-000030.md) | [37.0 d](/filings/0001770450-26-000040.md) |
| Capital expenditure | $m | [10.0 d](/filings/0001770450-24-000050.md) | [8.0 d](/filings/0001770450-26-000009.md) | [8.0](/filings/0001770450-25-000026.md) | [6.0 d](/filings/0001628280-25-038980.md) | [8.0 d](/filings/0001770450-25-000037.md) | [5.0 d](/filings/0001770450-26-000009.md) | [5.0](/filings/0001770450-26-000030.md) | [4.0 d](/filings/0001770450-26-000040.md) | [12.0 d](/filings/0001770450-25-000037.md) | [16.0 d](/filings/0001770450-26-000009.md) | [12.0](/filings/0001770450-26-000030.md) | [14.0 d](/filings/0001770450-26-000040.md) |
| Dividends paid | $m | [39.0 d](/filings/0001770450-24-000050.md) | [31.0 d](/filings/0001770450-26-000009.md) | [33.0](/filings/0001770450-25-000026.md) | [31.0 d](/filings/0001628280-25-038980.md) | [32.0 d](/filings/0001770450-25-000037.md) | [31.0 d](/filings/0001770450-26-000009.md) | [35.0](/filings/0001770450-26-000030.md) | [16.0 d](/filings/0001770450-26-000040.md) | [3.0 d](/filings/0001770450-25-000037.md) | [3.0 d](/filings/0001770450-26-000009.md) | [6.0](/filings/0001770450-26-000030.md) | [3.0 d](/filings/0001770450-26-000040.md) |
| Share repurchases | $m | [544 d](/filings/0001770450-24-000050.md) | [0.0 d](/filings/0001770450-26-000009.md) | [3.0](/filings/0001770450-25-000026.md) | [0.0 d](/filings/0001628280-25-038980.md) | [0.0 d](/filings/0001770450-25-000037.md) | [5.0 d](/filings/0001770450-26-000009.md) | [0.0](/filings/0001770450-25-000026.md) | [0.0 d](/filings/0001628280-25-038980.md) | [0.0 d](/filings/0001770450-25-000037.md) | [0.0 d](/filings/0001770450-26-000009.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [157](/filings/0001770450-24-000031.md) | [157](/filings/0001770450-24-000042.md) | [157](/filings/0001770450-24-000050.md) | [124](/filings/0001770450-25-000026.md) | [124](/filings/0001628280-25-038980.md) | [124](/filings/0001770450-25-000037.md) | [125](/filings/0001770450-25-000026.md) | [126](/filings/0001628280-25-038980.md) | [127](/filings/0001770450-25-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 131,314,511 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001770450-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.